Abstract:miRNAs are a class of small non-coding RNA molecules that play important roles in gene regulation. They are crucial for maintaining normal cellular functions, and dysregulation or dysfunction of miRNAs which are linked to the onset and advancement of multiple human diseases. Research on miRNAs has unveiled novel avenues in the realm of the diagnosis, treatment, and prevention of human diseases. However, clinical trials pose challenges and drawbacks, such as complexity and time-consuming processes, which create obstacles for many researchers. Graph Attention Network (GAT) has shown excellent performance in handling graph-structured data for tasks such as link prediction. Some studies have successfully applied GAT to miRNA-disease association prediction. However, there are several drawbacks to existing methods. Firstly, most of the previous models rely solely on concatenation operations to merge features of miRNAs and diseases, which results in the deprivation of significant modality-specific information and even the inclusion of redundant information. Secondly, as the number of layers in GAT increases, there is a possibility of excessive smoothing in the feature extraction process, which significantly affects the prediction accuracy. To address these issues and effectively complete miRNA disease prediction tasks, we propose an innovative model called Multiplex Adaptive Modality Fusion Graph Attention Network (MAMFGAT). MAMFGAT utilizes GAT as the main structure for feature aggregation and incorporates a multi-modal adaptive fusion module to extract features from three interconnected networks: the miRNA-disease association network, the miRNA similarity network, and the disease similarity network. It employs adaptive learning and cross-modality contrastive learning to fuse more effective miRNA and disease feature embeddings as well as incorporates multi-modal residual feature fusion to tackle the problem of excessive feature smoothing in GATs. Finally, we employ a Multi-Layer Perceptron (MLP) model that takes the embeddings of miRNA and disease features as input to anticipate the presence of potential miRNA-disease associations. Extensive experimental results provide evidence of the superior performance of MAMFGAT in comparison to other state-of-the-art methods. To validate the significance of various modalities and assess the efficacy of the designed modules, we performed an ablation analysis. Furthermore, MAMFGAT shows outstanding performance in three cancer case studies, indicating that it is a reliable method for studying the association between miRNA and diseases. The implementation of MAMFGAT can be accessed at the following GitHub repository: https://github.com/zixiaojin66/MAMFGAT-master .

Predicting Drug-miRNA Resistance with Layer Attention Graph Convolution Network and Multi Channel Feature Extraction.

MiRNA-Drug Resistance Association Prediction Through the Attentive Multimodal Graph Convolutional Network

Graph convolution for predicting associations between miRNA and drug resistance

ReHoGCNES-MDA: prediction of miRNA-disease associations using homogenous graph convolutional networks based on regular graph with random edge sampler

Predicting miRNA-disease associations via layer attention graph convolutional network model

Multi-view Multichannel Attention Graph Convolutional Network for miRNA-disease association prediction

LRGCPND: Predicting Associations between ncRNA and Drug Resistance via Linear Residual Graph Convolution

SMGCN: Multiple Similarity and Multiple Kernel Fusion Based Graph Convolutional Neural Network for Drug-Target Interactions Prediction.

Prediction of small molecule drug-miRNA associations based on GNNs and CNNs

Predicting miRNA-disease association via graph attention learning and multiplex adaptive modality fusion

GCFMCL: predicting miRNA-drug sensitivity using graph collaborative filtering and multi-view contrastive learning

Multi-layer graph attention neural networks for accurate drug-target interaction mapping

PGCNMDA: Learning node representations along paths with graph convolutional network for predicting miRNA-disease associations

GAM-MDR: probing miRNA–drug resistance using a graph autoencoder based on random path masking

Identification of genotypes of Giardia duodenalis human isolates in Isfahan, Iran, using polymerase chain reaction – Restriction Fragment Length polymorphism

BNEMDI: A Novel MicroRNA–Drug Interaction Prediction Model Based on Multi-Source Information With a Large-Scale Biological Network

Drug Sensitivity Prediction Based on Multi-stage Multi-modal Drug Representation Learning

Predicting miRNA-Disease Associations Based on Heterogeneous Graph Attention Networks

TDCMDA: Tripartite graph-based integrating dual-layer contrast learning into graph convolutional network for miRNA-disease association identification

Identification of associations between lncRNA and drug resistance based on deep learning and attention mechanism

Generative Adversarial Matrix Completion Network based on Multi-Source Data Fusion for miRNA–Disease Associations Prediction